Budesonide-formoterol reliever therapy in intermittent versus mild persistent asthma.
Papi A, Braithwaite I, Ebmeier S, Hancox RJ, Harrison T, Holliday M, Houghton C, Morandi L, Oldfield K, Pavord ID, Reddel HK, Williams M, Weatherall M, Beasley R; NovelSTART Study Team.
Papi A, et al. Among authors: weatherall m.
Eur Respir J. 2021 Feb 17;57(2):2003064. doi: 10.1183/13993003.03064-2020. Print 2021 Feb.
Eur Respir J. 2021.
PMID: 33060151
Free article.
No abstract available.